PlainHospital

DAVOL INC., SUB. C.R. BARD, INC. -1213643

Manufacturer adverse-event records for DAVOL INC., SUB. C.R. BARD, INC. -1213643 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2008–2026 · mid-book · typical Death-code · injury-heavy

Injury-mix signature

DAVOL INC., SUB. C.R. BARD, INC. -1213643 leans injury-heavy in event_type mix

Injury-coded event_type share is 84.0% (injury-heavy tercile) beside 0.45% Death-coded (typical). Volume band: mid.

What the Injury-mix reading shows for DAVOL INC., SUB. C.R. BARD, INC. -1213643

The standout signal for DAVOL INC., SUB. C.R. BARD, INC. -1213643 is Injury-mix: 84.0% Injury-coded (injury-heavy) beside 0.45% Death-coded, on a mid-book footprint.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for DAVOL INC., SUB. C.R. BARD, INC. -1213643. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 15 device types, led in this extract by Injury at 8,744 (84.0% of event_type total). Peak single-year volume reaches 2,463 reports across 15 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

10,414
Total Reports
47
Event-type Death
8,744
Injury Reports
15
Device Types

Event Types

Injury 8,744 (84.0%)
Malfunction 1,623 (15.6%)
Death 47 (0.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 4,618 (30.8%)
Disability 3,844 (25.7%)
R 3,442 (23.0%)
Other 1,780 (11.9%)
S 902 (6.0%)
L 118 (0.8%)
Hospitalization 82 (0.5%)
Life Threatening 61 (0.4%)
H 47 (0.3%)
O 40 (0.3%)
D 33 (0.2%)
Death 16 (0.1%)
1 (0.0%)
C 1 (0.0%)

Devices (15)

Device Reports
Mesh, Surgical, Polymeric 8,807
Staple, Implantable 768
Laparoscope, General & Plastic Surgery 281
Surgical Film 188
Mesh, Surgical, Absorbable, Abdominal Hernia 157
Agent, Absorbable Hemostatic, Non-Collagen Based 83
Mesh, Surgical 58
Lavage, Jet 22
Agent, Absorbable Hemostatic, Collagen Based 18
Collagen Surgical Mesh Containing Drugs 17
Laparoscope, Gynecologic (And Accessories) 7
Electrosurgical, Cutting & Coagulation & Accessories 3
Apparatus, Suction, Single Patient Use, Portable, Nonpowered 2
Sealant, Polymerizing 2
Hemostatic Wound Dressing Without Thrombin Or Other Biologics 1

Yearly Trend

08
2008: 1
13
2013: 7
14
2014: 8
15
2015: 7
16
2016: 5
17
2017: 7
18
2018: 601
19
2019: 2,463
20
2020: 2,249
21
2021: 1,285
22
2022: 929
23
2023: 642
24
2024: 604
25
2025: 1,307
26
2026: 299

Read our methodology - how this data is sourced, computed, and verified.